Skip to content

Effect of closed-loop target controlled infusion of propofol on blood pressure in general anesthesia

Effect of closed-loop target controlled infusion of propofol on blood pressure in general anesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040785
Enrollment
Unknown
Registered
2020-12-10
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

general anesthesia

Interventions

Group M:propofol TCI
Group C1:propofol closed-loop TCI,BIS 55
Group C2:propofol closed-loop TCI,BIS 50
Group C3:propofol closed-loop TCI,BIS 45

Sponsors

Plastic Surgery hospital(institute), CAMS, PUMC
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. general anesthesia should be selected for selective operation and operation time >60min; 2. ASA grade I or II; 3. aged 18-50 years old; 4. BMI<30kg/m2; 5. Understand the informed consent and agree to sign the informed consent before the study.

Exclusion criteria

Exclusion criteria: 1. overstrain; 2. the cardiovascular, respiratory, neurological and endocrine system diseases; 3. the abnormal function of the liver and kidney; 4. the drug history of alcohol dependence; 5. the abnormal airway; 6. the hearing, intelligence and communication barriers; 7. patients can not use BIS electrode in the forehead.

Design outcomes

Primary

MeasureTime frame
BIS;blood pressure;percetage of BIS time in the property interval;Propofol plasma target concentration;Regulation of the target concentration of propofol;awake time;total amount of propofol;Controlled Hypotensive Drugs;satisfaction of doctor and patient;

Countries

China

Contacts

Public ContactWenli XU

Plastic Surgery hospital(institute), CAMS, PUMC

xwllily@163.com+86 15201155646

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026